Paris-based Isochem makes fine chemicals and phosgene derivatives for the pharmaceutical, cosmetics, agrochemicals and intermediates industries and generates revenues of around €113m a year.
Isochem has a manufacturing network consisting of four facilities in France, one in Kazincbarcika, Hungary, and is also represented in the US, Great Britain and Germany.
SNPE CEO Antoine Gendry said that: “Aurelius is a strong and serious partner for the successful future Isochem.”
Aurelius said its new acquisition has considerable opportunities for growth in new markets and by developing new products, technologies and customer-specific solutions.
The Munich-based group added that it “plans to intensify [Isochem’s] international distribution especially in the US and in Eastern Europe and to improve all operational processes.”